Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 10Completed 7Withdrawn 3Terminated 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Recurrence 1Neoplasm Recurrence, Local 1Liver Neoplasms 1Liver Cirrhosis 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Ethiodized Oil × Clear all
NCT03727633 2026-03-31

LIDA-BII

University Hospital, Montpellier

Phase 2 Terminated
44 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02762266 2024-03-12

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Stanford University

Phase 3 Terminated
13 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT00470340 2011-05-05

GEMOXIAL

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
263 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms, Neoplasm Recurrence, Local, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡